Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_plaque_web

AstraZeneca vaccine age restrictions has ended reports of rare clots

August 12, 2021

After the UK’s decision to restrict the use of AstraZeneca’s vaccine in under 40s there have been no new cases …

News
who_flag

WHO to launch trial investigating anti-inflammatory drugs for COVID patients

August 12, 2021

The World Health Organization (WHO) announced on Wednesday that a clinical trial is to begin to study three anti-inflammatory drugs …

News

EMA investigating Pfizer and Moderna vaccine side effects

August 12, 2021

The EMA has launched an investigation into the Pfizer and Moderna vaccines after three new conditions have been reported as …

News

NICE approves Eli Lilly’s abemaciclib for advanced breast cancer

August 12, 2021

NICE has approved Eli Lilly’s abemaciclib, given with fulvestrant, for hormone receptor-positive HER2-negative breast cancer which has spread to other …

News

Cannabidiol gains MHRA approval as adjunctive treatment of seizures

August 11, 2021
Research and Development

GW Pharmaceuticals has announced that is has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for …

News
andrei_r_-_shutterstock_1935537274_720

Janssen’s MS treatment Ponvory is granted UK marketing authorisation

August 11, 2021
Research and Development

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Marketing Authorisation in Great Britain for PONVORY (ponesimod) for the …

News

Sputnik V vaccine 13% less effective against Delta than originally reported

August 11, 2021
Medical Communications, Research and Development

Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, …

News
cdc-un8tv9pw2ik-unsplash_1

More than 75% of UK adults have been double jabbed

August 11, 2021
Research and Development

More than 75% of adults living in the UK have now received both doses of the vaccine, as announced by …

News

Moderna and Canada to collaborate on mRNA manufacturing

August 11, 2021
Manufacturing and Production, Research and Development

Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …

News
gilead-sciences

Kite receives positive recommendation from SMC for CAR T therapy

August 10, 2021
Manufacturing and Production, Research and Development

Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …

News
laboratory-testing-az

Researchers develop injectable hydrogel to combat Parkinson’s

August 10, 2021
Medical Communications, Research and Development

An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …

News

AI system may be able to detect dementia in a day

August 10, 2021
Manufacturing and Production, Medical Communications, Research and Development

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …

News

Moderna could offer better defence against Delta variant than Pfizer

August 10, 2021
Manufacturing and Production

Pfizer-BioNTech’s mRNA could be less effective than Moderna’s against the Delta variant of COVID-19. In a study of more than …

News
pfizer_building_logo2_1

Scotland approves Merck and Pfizer’s Bavencio for bladder cancer

August 10, 2021
Manufacturing and Production

Merck and Pfizer’s Bavencio (avelumab) has been approved by approved by the Scottish Medicines Consortium (SMC) for use via NHS …

News

Researchers develop new method to kill bacteria on medical implants

August 9, 2021
Medical Communications, Research and Development, Sales and Marketing

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …

News

‘Potential’ link between vaccines and menstruation changes

August 9, 2021
Sales and Marketing

France’s health body has said changes in women’s menstrual cycles are a “potential” side effect of receiving the Moderna or …

News

Psoriasis treatment bimekizumab maintains high Levels of skin clearance

August 9, 2021
Sales and Marketing

New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …

News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021
Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …

News

FDA approves Nexviazyme as treatment for late-onset Pompe disease

August 9, 2021
Sales and Marketing

The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …

News
az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021
Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025